Literature DB >> 17364020

Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes.

Todd T Brown1, Amy B Wisniewski, Adrian S Dobs.   

Abstract

Opiates and cocaine both have effects on adrenal and gonadal function. Opiates suppress the hypothalamic-pituitary adrenal (HPA) axis, whereas cocaine leads to HPA activation. Opiates also cause gonadal dysfunction in both men and women. During withdrawal from opiates and cocaine, the HPA axis is activated which may reinforce relapse behavior. This review describes these hormonal effects and explores the potential consequences, including the effects on mood cognition and cardiovascular risk. Modification of the drug-induced hormonal dysfunction may represent a treatment strategy for drug rehabilitation.

Entities:  

Year:  2006        PMID: 17364020      PMCID: PMC1821355          DOI: 10.3844/ajidsp.2006.130.135

Source DB:  PubMed          Journal:  Am J Infect Dis        ISSN: 1553-6203


  45 in total

1.  Ketoconazole reduces low dose cocaine self-administration in rats.

Authors:  N E Goeders; R L Peltier; G F Guerin
Journal:  Drug Alcohol Depend       Date:  1998-12-01       Impact factor: 4.492

Review 2.  Cocaine's effects on neuroendocrine systems: clinical and preclinical studies.

Authors:  N K Mello; J H Mendelson
Journal:  Pharmacol Biochem Behav       Date:  1997-07       Impact factor: 3.533

3.  Mechanism of action of narcotics in the production of menstrual dysfunction in women.

Authors:  F J Santen; J Sofsky; N Bilic; R Lippert
Journal:  Fertil Steril       Date:  1975-06       Impact factor: 7.329

4.  Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal.

Authors:  S.C. Heinrichs; F. Menzaghi; G. Schulteis; G.F. Koob; L. Stinus
Journal:  Behav Pharmacol       Date:  1995-01       Impact factor: 2.293

5.  The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer.

Authors:  J C Smith; S Bennett; L M Evans; H G Kynaston; M Parmar; M D Mason; J R Cockcroft; M F Scanlon; J S Davies
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.

Authors:  R Pasquali; S Cantobelli; F Casimirri; M Capelli; L Bortoluzzi; R Flamia; A M Labate; L Barbara
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

Review 7.  Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression.

Authors:  Shalender Bhasin
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

Review 8.  Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.

Authors:  Odelia B Cooper; Todd T Brown; Adrian S Dobs
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

9.  A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men.

Authors:  A S Burris; S M Banks; C S Carter; J M Davidson; R J Sherins
Journal:  J Androl       Date:  1992 Jul-Aug

10.  The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats.

Authors:  Rong Chen; Gregory Osterhaus; Todd McKerchar; Stephen C Fowler
Journal:  Neurosci Lett       Date:  2003-11-20       Impact factor: 3.046

View more
  9 in total

1.  Hormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance Abuse.

Authors:  Jag H Khalsa; Frank Vocci; Adrian Dobs
Journal:  Am J Infect Dis       Date:  2006

2.  Relationship between sex hormones and cognitive performance in men with substance use.

Authors:  Mihail F Zilbermint; Amy B Wisniewski; Xiaoqiang Xu; Ola A Selnes; Adrian S Dobs
Journal:  Drug Alcohol Depend       Date:  2012-09-26       Impact factor: 4.492

3.  Dopamine Receptor D1 Contributes to Cocaine Epigenetic Reprogramming of Histone Modifications in Male Germ Cells.

Authors:  Betina González; Samanta N Gancedo; Sahira A Janeir Garazatua; Eduardo Roldán; Alfredo D Vitullo; Candela R González
Journal:  Front Cell Dev Biol       Date:  2020-04-03

4.  HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone's Psychomotor Effects in Female Mice.

Authors:  Mohammed F Salahuddin; Fakhri Mahdi; Suresh P Sulochana; Jason J Paris
Journal:  Viruses       Date:  2021-04-30       Impact factor: 5.048

5.  Adrenal crisis during pregnancy: Case report and obstetric perspective.

Authors:  Barbara Gardella; Andrea Gritti; Annachiara Licia Scatigno; Anna Maria Clelia Gallotti; Francesca Perotti; Mattia Dominoni
Journal:  Front Med (Lausanne)       Date:  2022-09-14

6.  Psychostimulant-Induced Testicular Toxicity in Mice: Evidence of Cocaine and Caffeine Effects on the Local Dopaminergic System.

Authors:  Candela R González; Betina González; María E Matzkin; Javier A Muñiz; Jean Lud Cadet; Edgar Garcia-Rill; Francisco J Urbano; Alfredo D Vitullo; Veronica Bisagno
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

Review 7.  Reactive oxygen species and male reproductive hormones.

Authors:  Mahsa Darbandi; Sara Darbandi; Ashok Agarwal; Pallav Sengupta; Damayanthi Durairajanayagam; Ralf Henkel; Mohammad Reza Sadeghi
Journal:  Reprod Biol Endocrinol       Date:  2018-09-11       Impact factor: 5.211

8.  Gonadal and Cortisol Hormone Profile among Male Chronic Khat, Marijuana, and Heroin Abuses.

Authors:  Meseret Yibrah; Abebe Edao Negesso; Atsbeha Gebregziabher; Feyissa Challa; Kissi Mudi; Feven Tesfay; Mehari Gebretsadkan; Samuel Kinde; Daniel Asmelash
Journal:  Int J Endocrinol       Date:  2019-11-03       Impact factor: 3.257

9.  Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans.

Authors:  Bao-Zhu Yang; Hang Zhou; Zhongshan Cheng; Henry R Kranzler; Joel Gelernter
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.